\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ patient\\ is\\ currently\\ undergoing\\ radiation\\ therapy\\.\ \(0\)\
\-\ ct\\:\\ low\\ attenuation\\ focus\\ in\\ the\\ post\\ left\\ parietal\\ lobe\\,\\ with\\ surrounding\\ vasogenic\\ edema\\.\\ second\\ lesion\\ in\\ the\\ left\\ temporal\\ lobe\\,\\ with\\ irregular\\ central\\ high\\ attenuation\\ consistent\\ with\\ hemorrhage\\.\\ there\\ is\\ not\\ a\\ clear\\ connection\\ between\\ the\\ two\\ discrete\\ lesions\\.\\ the\\ cerebral\\ sulci\\ and\\ left\\ lateral\\ ventricle\\ are\\ effaced\\,\\ and\\ there\\ is\\ mild\\ midline\\ shift\\.\ \(0\)\
\-\ mr\\:\\ left\\ posterior\\ parietal\\ and\\ left\\ temporal\\ lesions\\ with\\ peripheral\\ enhancement\\,\\ and\\ surrounding\\ vasogenic\\ edema\\.\\ the\\ temporal\\ lesion\\ has\\ very\\ low\\ central\\ signal\\ on\\ t2\\ weighted\\ images\\.\\ mass\\ effect\\ as\\ seen\\ on\\ ct\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ ddx\\:\\ the\\ primary\\ differential\\ for\\ most\\ brain\\ lesions\\ is\\ metastatic\\ disease\\ vs\\.\\ primary\\ malignancy\\ vs\\ infection\\ \\(abscess\\)\\.\\ a\\ mnemonic\\ for\\ ring\\ enhancing\\ lesions\\ is\\ magical\\ dr\\:\ \(0\)\
\-\ metastatic\\ disease\\ \\‚\\Ä\\ì\\ may\\ favor\\ due\\ to\\ multiplicity\\ and\\ \ \(0\)\
\-\ \\ \\ hemorrhage\ \(2\)\
\-\ abscess\\/cerebritis\\ \\‚\\Ä\\ì\\ hemorrhage\\ would\\ be\\ atypical\\,and\\ \\ \ \(0\)\
\-\ \\ \\ not\\ febrile\ \(1\)\
\-\ gbm\\ \\‚\\Ä\\ì\\ multicentric\\ gbm\\ also\\ common\\,\\ and\\ can\\ hemorrhage\ \(0\)\
\-\ ischemic\\:\\ hemorrhagic\\ stroke\\ \\‚\\Ä\\ì\\ despite\\ known\\ \ \(0\)\
\-\ \\ \\ hypertension\\,\\ unlikely\\ to\\ have\\ defined\\ enhancing\\ \ \(1\)\
\-\ \\ \\ tissue\ \(3\)\
\-\ contusion\\ \\‚\\Ä\\ì\\ no\\ history\\ of\\ trauma\\,\\ and\\ unlikely\\ with\\ \ \(0\)\
\-\ \\ \\ enhancing\\ soft\\ tissue\\ mass\ \(1\)\
\-\ aids\\:\\ toxo\\ \\‚\\Ä\\ì\\ no\\ history\\ to\\ suggest\ \(0\)\
\-\ lymphoma\\ \\‚\\Ä\\ì\\ would\\ be\\ atypical\\ in\\ an\\ otherwise\\ healthy\\ \ \(0\)\
\-\ \\ \\ individual\ \(1\)\
\-\ demylinating\\ disease\\ \\‚\\Ä\\ì\\ hemorrhage\\ would\\ be\\ \ \(0\)\
\-\ \\ \\ uncharateristic\\,\\ and\\ not\\ comon\ \(1\)\
\-\ radiation\\ necrosis\\ \\‚\\Ä\\ì\\ no\\ history\\ of\\ radiation\\ therapy\ \(0\)\
\-\ 61\\ year\\ old\\ white\\ male\\ with\\ 2\\ weeks\\ of\\ difficulty\\ concentrating\\ and\\ remembering\\,\\ slower\\ movements\\.\\ high\\ blood\\ pressure\\,\\ otherwise\\ healthy\\,\\ though\\ wife\\ has\\ noticed\\ subtle\\ changes\\ in\\ mentation\\ over\\ last\\ 6\\ months\ \(0\)\
\-\ this\\ gentleman\\‚\\Ä\\ôs\\ acute\\ presentation\\ is\\ likely\\ due\\ to\\ acute\\ hemorrhage\\.\ \(0\)\
\-\ gbms\\ are\\ the\\ most\\ malignant\\ of\\ all\\ gliomas\\ \\(who\\ grade\\ iv\\)\\.\\ they\\ are\\ the\\ most\\ common\\ primary\\ brain\\ tumor\\,\\ occuring\\ in\\ all\\ ages\\ with\\ peak\\ at\\ 65\\-75\\ years\\ of\\ age\\.\\ the\\ are\\ more\\ common\\ in\\ men\\ \\(men\\ \\>\\ women\\ 3\\:2\\)\\,\\ and\\ more\\ common\\ in\\ whites\\.\\ they\\ can\\ be\\ associated\\ with\\ certain\\ conditions\\,\\ to\\ included\\ turcot\\ syndrome\\,\\ neurofibromatosis\\ type\\-1\\ and\\ li\\-faumeni\\ syndrome\\.\\ gbms\\ prefer\\ the\\ hemispheric\\ white\\ matter\\,\\ frontal\\ more\\ than\\ temporal\\.\\ \ \(0\)\
\-\ gbms\\ are\\ most\\ commonly\\ a\\ solitary\\ lesion\\,\\ but\\ they\\ can\\ be\\ multifocal\\ in\\ 2\\-5\\%\\ of\\ cases\\.\\ 5\\%\\ of\\ lesions\\ will\\ present\\ with\\ hemorrhage\\;\\ they\\ rarely\\ calcify\\.\\ they\\ can\\ also\\ present\\ as\\ a\\ \\‚\\Ä\\úbutterfly\\ glioma\\,\\‚\\Ä\\ù\\ crossing\\ the\\ midline\\,\\ usually\\ across\\ the\\ corpus\\ callosum\\.\\ they\\ can\\ present\\ as\\ a\\ primary\\ leptomeningeal\\ tumor\\,\\ or\\ metastasize\\ by\\ meningeal\\ or\\ subependymal\\ routes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.07795348225115874\ \(0\)\
\-\ gbms\\:\\ 0\\.05214125767093506\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.044841883083856414\ \(0\)\
\-\ they\\:\\ 0\\.041607380087666304\ \(0\)\
\-\ temporal\\:\\ 0\\.0308278457442715\ \(0\)\
\-\ lesions\\:\\ 0\\.02576081651288229\ \(0\)\
\-\ primary\\:\\ 0\\.02280526362969096\ \(0\)\
\-\ gbm\\:\\ 0\\.022767199586815026\ \(0\)\
\-\ can\\:\\ 0\\.0218268282935706\ \(0\)\
\-\ men\\:\\ 0\\.02174114584415416\ \(0\)\
\-\ vasogenic\\:\\ 0\\.020837223792522848\ \(0\)\
\-\ would\\:\\ 0\\.02054707350285196\ \(0\)\
\-\ common\\:\\ 0\\.02014655145906664\ \(0\)\
\-\ magical\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ toxo\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ uncharateristic\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ comon\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ remembering\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ type\\-1\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ li\\-faumeni\\:\\ 0\\.01985477122514977\ \(0\)\
\-\ radiation\\:\\ 0\\.018947643578123896\ \(0\)\
\-\ unlikely\\:\\ 0\\.018335974304519137\ \(0\)\
\-\ abscess\\/cerebritis\\:\\ 0\\.018293628926591334\ \(0\)\
\-\ mentation\\:\\ 0\\.018293628926591334\ \(0\)\
\-\ 65\\-75\\:\\ 0\\.018293628926591334\ \(0\)\
\-\ turcot\\:\\ 0\\.018293628926591334\ \(0\)\
\-\ enhancing\\:\\ 0\\.01810779414111324\ \(0\)\
\-\ most\\:\\ 0\\.0177732895651178\ \(0\)\
\-\ 3\\:2\\:\\ 0\\.01738041922364502\ \(0\)\
\-\ healthy\\:\\ 0\\.017354386458137798\ \(0\)\
\-\ routes\\:\\ 0\\.0167324866280329\ \(0\)\
\-\ atypical\\:\\ 0\\.01668257043067547\ \(0\)\
\-\ parietal\\:\\ 0\\.01644474076595939\ \(0\)\
\-\ effaced\\:\\ 0\\.016229911062009904\ \(0\)\
\-\ demylinating\\:\\ 0\\.016229911062009904\ \(0\)\
\-\ prefer\\:\\ 0\\.016229911062009904\ \(0\)\
\-\ concentrating\\:\\ 0\\.015819276925086584\ \(0\)\
\-\ attenuation\\:\\ 0\\.015475770587504678\ \(0\)\
\-\ multiplicity\\:\\ 0\\.015472090709259425\ \(0\)\
\-\ slower\\:\\ 0\\.015472090709259425\ \(0\)\
\-\ \\:\\:\\ 0\\.015273983999873854\ \(0\)\
\-\ mnemonic\\:\\ 0\\.015171344329474465\ \(0\)\
\-\ multicentric\\:\\ 0\\.015171344329474465\ \(0\)\
\-\ vs\\:\\ 0\\.015155315181985575\ \(0\)\
\-\ midline\\:\\ 0\\.014892477870894238\ \(0\)\
\-\ be\\:\\ 0\\.014839602740359562\ \(0\)\
\-\ wife\\:\\ 0\\.01466876876345147\ \(0\)\
\-\ whites\\:\\ 0\\.01466876876345147\ \(0\)\
\-\ 2\\-5\\:\\ 0\\.01466876876345147\ \(0\)\
\-\ more\\:\\ 0\\.014440380468325449\ \(0\)\
\-\ butterfly\\:\\ 0\\.014258134626528148\ \(0\)\
\-\ occuring\\:\\ 0\\.014077858257894057\ \(0\)\
\-\ hemispheric\\:\\ 0\\.014077858257894057\ \(0\)\
\-\ otherwise\\:\\ 0\\.013825744294713265\ \(0\)\
\-\ gentleman\\:\\ 0\\.013610202030916028\ \(0\)\
\-\ metastasize\\:\\ 0\\.013610202030916028\ \(0\)\
\-\ calcify\\:\\ 0\\.013344924923581834\ \(0\)\
\-\ favor\\:\\ 0\\.013223151902702833\ \(0\)\
\-\ are\\:\\ 0\\.013117949014972992\ \(0\)\
\-\ present\\:\\ 0\\.013040599688727573\ \(0\)\
\-\ dr\\:\\ 0\\.012892963897766176\ \(0\)\
\-\ \\,\\:\\ 0\\.01280385445014197\ \(0\)\
\-\ white\\:\\ 0\\.012766235192396476\ \(0\)\
\-\ gliomas\\:\\ 0\\.012696992327969711\ \(0\)\
\-\ crossing\\:\\ 0\\.012696992327969711\ \(0\)\
\-\ central\\:\\ 0\\.012665006111981798\ \(0\)\
\-\ surrounding\\:\\ 0\\.012653897587228673\ \(0\)\
\-\ certain\\:\\ 0\\.012349806112142554\ \(0\)\
\-\ individual\\:\\ 0\\.012270771608063117\ \(0\)\
\-\ meningeal\\:\\ 0\\.012270771608063117\ \(0\)\
\-\ aids\\:\\ 0\\.012049059732357594\ \(0\)\
\-\ connection\\:\\ 0\\.01184723054611956\ \(0\)\
\-\ lesion\\:\\ 0\\.011760508283786856\ \(0\)\
\-\ brain\\:\\ 0\\.011582664519381811\ \(0\)\
\-\ subependymal\\:\\ 0\\.011490870174013942\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.011436596409196238\ \(0\)\
\-\ 61\\:\\ 0\\.011331821599207741\ \(0\)\
\-\ multiforme\\:\\ 0\\.011183267617694684\ \(0\)\
\-\ not\\:\\ 0\\.011124492538215633\ \(0\)\
\-\ discrete\\:\\ 0\\.01108941019336908\ \(0\)\
\-\ febrile\\:\\ 0\\.01108941019336908\ \(0\)\
\-\ syndrome\\:\\ 0\\.011008588183489376\ \(0\)\
\-\ sulci\\:\\ 0\\.01099930808838327\ \(0\)\
\-\ peak\\:\\ 0\\.010955573660777186\ \(0\)\
\-\ ages\\:\\ 0\\.010912672320753101\ \(0\)\
\-\ edema\\:\\ 0\\.010887042745185994\ \(0\)\
\-\ all\\:\\ 0\\.010887042745185994\ \(0\)\
\-\ left\\:\\ 0\\.010766951230550841\ \(0\)\
\-\ low\\:\\ 0\\.010703459697596394\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.010633274463388284\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.01059604630584051\ \(0\)\
\-\ contusion\\:\\ 0\\.01059604630584051\ \(0\)\
\-\ high\\:\\ 0\\.010533991266111781\ \(0\)\
\-\ noticed\\:\\ 0\\.010523386706249922\ \(0\)\
\-\ movements\\:\\ 0\\.01045299809475419\ \(0\)\
\-\ lobe\\:\\ 0\\.010357321387042945\ \(0\)\
\-\ multifocal\\:\\ 0\\.010351375492771151\ \(0\)\
\-\ therapy\\:\\ 0\\.0102911747578406\ \(0\)\
\-\ across\\:\\ 0\\.010286088247561123\ \(0\)\
\-\ due\\:\\ 0\\.010271518706994774\ \(0\)\
\-\ ddx\\:\\ 0\\.010160930925140378\ \(0\)\
\-\ stroke\\:\\ 0\\.01004236395783087\ \(0\)\
\-\ callosum\\:\\ 0\\.009875454110637802\ \(0\)\
\-\ metastatic\\:\\ 0\\.009689681998270677\ \(0\)\
\-\ conditions\\:\\ 0\\.009574707730852844\ \(0\)\
\-\ solitary\\:\\ 0\\.009551368120412422\ \(0\)\
\-\ acute\\:\\ 0\\.00950396094192115\ \(0\)\
\-\ corpus\\:\\ 0\\.009482766301753168\ \(0\)\
\-\ undergoing\\:\\ 0\\.009438165789824834\ \(0\)\
\-\ disease\\:\\ 0\\.009437415819025028\ \(0\)\
\-\ ischemic\\:\\ 0\\.00937287854461481\ \(0\)\
\-\ women\\:\\ 0\\.009351530022194665\ \(0\)\
\-\ rarely\\:\\ 0\\.009227521515025683\ \(0\)\
\-\ shift\\:\\ 0\\.009129154254884555\ \(0\)\
\-\ tissue\\:\\ 0\\.009123518866903576\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.008980190735730174\ \(0\)\
\-\ \\%\\:\\ 0\\.008978923573630665\ \(0\)\
\-\ tumor\\:\\ 0\\.008974019376625276\ \(0\)\
\-\ ring\\:\\ 0\\.008944439949342133\ \(0\)\
\-\ despite\\:\\ 0\\.008944439949342133\ \(0\)\
\-\ though\\:\\ 0\\.008926775135240723\ \(0\)\
\-\ included\\:\\ 0\\.008874597073795825\ \(0\)\
\-\ subtle\\:\\ 0\\.008840471386812487\ \(0\)\
\-\ as\\:\\ 0\\.008733631796581945\ \(0\)\
\-\ glioma\\:\\ 0\\.008677193229068899\ \(0\)\
\-\ focus\\:\\ 0\\.008645911444923252\ \(0\)\
\-\ difficulty\\:\\ 0\\.008569556598806852\ \(0\)\
\-\ weighted\\:\\ 0\\.008368585576897071\ \(0\)\
\-\ last\\:\\ 0\\.008222370382979695\ \(0\)\
\-\ suggest\\:\\ 0\\.00819677633196547\ \(0\)\
\-\ defined\\:\\ 0\\.008109420419724128\ \(0\)\
\-\ history\\:\\ 0\\.007974422552074888\ \(0\)\
\-\ irregular\\:\\ 0\\.007676456424563918\ \(0\)\
\-\ currently\\:\\ 0\\.00762651530408121\ \(0\)\
\-\ is\\:\\ 0\\.007598524032226023\ \(0\)\
\-\ necrosis\\:\\ 0\\.007597073678929515\ \(0\)\
\-\ in\\:\\ 0\\.007592742885409998\ \(0\)\
\-\ also\\:\\ 0\\.0075883765480637445\ \(0\)\
\-\ hypertension\\:\\ 0\\.00758734471238781\ \(0\)\
\-\ matter\\:\\ 0\\.0075776575909927875\ \(0\)\
\-\ pressure\\:\\ 0\\.007558407454554819\ \(0\)\
\-\ malignancy\\:\\ 0\\.007437138913967378\ \(0\)\
\-\ second\\:\\ 0\\.0073921822865742745\ \(0\)\
\-\ grade\\:\\ 0\\.00733071349763732\ \(0\)\
\-\ commonly\\:\\ 0\\.007262458205981174\ \(0\)\
\-\ has\\:\\ 0\\.007228378245469721\ \(0\)\
\-\ ventricle\\:\\ 0\\.007212590805356819\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.007188065130133242\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.007147773317631496\ \(0\)\
\-\ clear\\:\\ 0\\.007116050930510463\ \(0\)\
\-\ iv\\:\\ 0\\.0070234795888763375\ \(0\)\
\-\ very\\:\\ 0\\.006986003645173714\ \(0\)\
\-\ peripheral\\:\\ 0\\.006963813788320084\ \(0\)\
\-\ malignant\\:\\ 0\\.006956465487340768\ \(0\)\
\-\ effect\\:\\ 0\\.006814320389795596\ \(0\)\
\-\ cerebral\\:\\ 0\\.00666767230127043\ \(0\)\
\-\ presentation\\:\\ 0\\.006629280708313249\ \(0\)\
\-\ available\\:\\ 0\\.006470087947837381\ \(0\)\
\-\ cases\\:\\ 0\\.0064117361801376855\ \(0\)\
\-\ \\>\\:\\ 0\\.006394521429433703\ \(0\)\
\-\ mr\\:\\ 0\\.006115314126005482\ \(0\)\
\-\ differential\\:\\ 0\\.006110269885930022\ \(0\)\
\-\ between\\:\\ 0\\.006100215171676224\ \(0\)\
\-\ known\\:\\ 0\\.006090205145188783\ \(0\)\
\-\ abscess\\:\\ 0\\.006085216766068169\ \(0\)\
\-\ post\\:\\ 0\\.006060439263676337\ \(0\)\
\-\ frontal\\:\\ 0\\.006045702555142697\ \(0\)\
\-\ will\\:\\ 0\\.006021353644998067\ \(0\)\
\-\ age\\:\\ 0\\.005857906138613303\ \(0\)\
\-\ usually\\:\\ 0\\.005844433004204412\ \(0\)\
\-\ no\\:\\ 0\\.0058138118290797436\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.005752312476678955\ \(0\)\
\-\ 6\\:\\ 0\\.0057480183814749425\ \(0\)\
\-\ there\\:\\ 0\\.005728448452544994\ \(0\)\
\-\ years\\:\\ 0\\.0056514485067983835\ \(0\)\
\-\ 5\\:\\ 0\\.00563099194244181\ \(0\)\
\-\ infection\\:\\ 0\\.005594631923587404\ \(0\)\
\-\ s\\:\\ 0\\.005519746998005826\ \(0\)\
\-\ changes\\:\\ 0\\.005515873820349236\ \(0\)\
\-\ two\\:\\ 0\\.00551200729192794\ \(0\)\
\-\ lymphoma\\:\\ 0\\.005500447374751094\ \(0\)\
\-\ weeks\\:\\ 0\\.005462337290317902\ \(0\)\
\-\ t2\\:\\ 0\\.005447272001689982\ \(0\)\
\-\ likely\\:\\ 0\\.0054285810043595865\ \(0\)\
\-\ ct\\:\\ 0\\.005384250690955148\ \(0\)\
\-\ mass\\:\\ 0\\.005353427959223263\ \(0\)\
\-\ trauma\\:\\ 0\\.005263533292247588\ \(0\)\
\-\ months\\:\\ 0\\.005256624537590242\ \(0\)\
\-\ blood\\:\\ 0\\.005253178091237161\ \(0\)\
\-\ enhancement\\:\\ 0\\.00515875848225909\ \(0\)\
\-\ signal\\:\\ 0\\.005074491734848601\ \(0\)\
\-\ mild\\:\\ 0\\.005068138409754813\ \(0\)\
\-\ than\\:\\ 0\\.005042902826392508\ \(0\)\
\-\ who\\:\\ 0\\.005017946867436266\ \(0\)\
\-\ over\\:\\ 0\\.004900095923738654\ \(0\)\
\-\ \\(\\:\\ 0\\.0048808224746206795\ \(0\)\
\-\ and\\:\\ 0\\.004865108263032931\ \(0\)\
\-\ \\)\\:\\ 0\\.004821200622387197\ \(0\)\
\-\ to\\:\\ 0\\.004809325545529124\ \(0\)\
\-\ consistent\\:\\ 0\\.004719140245115322\ \(0\)\
\-\ soft\\:\\ 0\\.004686771990976464\ \(0\)\
\-\ \\;\\:\\ 0\\.004561759433451788\ \(0\)\
\-\ associated\\:\\ 0\\.004541582346638968\ \(0\)\
\-\ or\\:\\ 0\\.004511363734070755\ \(0\)\
\-\ a\\:\\ 0\\.004466213984443708\ \(0\)\
\-\ posterior\\:\\ 0\\.004436122857437947\ \(0\)\
\-\ may\\:\\ 0\\.00422146029031109\ \(0\)\
\-\ have\\:\\ 0\\.004167653329651108\ \(0\)\
\-\ lateral\\:\\ 0\\.004159162264920158\ \(0\)\
\-\ 2\\:\\ 0\\.004144379496645374\ \(0\)\
\-\ but\\:\\ 0\\.004104737164489949\ \(0\)\
\-\ seen\\:\\ 0\\.0038032153492515543\ \(0\)\
\-\ the\\:\\ 0\\.0037364671541520486\ \(0\)\
\-\ images\\:\\ 0\\.0036920357926787254\ \(0\)\
\-\ male\\:\\ 0\\.0034801926528997143\ \(0\)\
\-\ for\\:\\ 0\\.00328427093983205\ \(0\)\
\-\ on\\:\\ 0\\.0032607703259703966\ \(0\)\
\-\ by\\:\\ 0\\.0032046641964974657\ \(0\)\
\-\ an\\:\\ 0\\.002661407351992635\ \(0\)\
\-\ at\\:\\ 0\\.002607574668539714\ \(0\)\
\-\ with\\:\\ 0\\.00237170627209236\ \(0\)\
\-\ this\\:\\ 0\\.0021647234534102095\ \(0\)\
\-\ year\\:\\ 0\\.002153390246110168\ \(0\)\
\-\ old\\:\\ 0\\.001970573416356429\ \(0\)\
\-\ patient\\:\\ 0\\.0019292611056675405\ \(0\)\
\-\ of\\:\\ 0\\.0018367716342025202\ \(0\)\
\-\ \\.\\:\\ 0\\.0016790321127123239\ \(0\)\
